Arthritis Awareness Month: The Right Time to Look at Joint Care Alternatives

Research shows popular remedies could be ineffective or carry serious
health risks

MANCHESTER, N.H.–(BUSINESS WIRE)–May is National Arthritis Awareness month, an occasion to highlight a
disease that affects over 50 million Americans and is the number one
cause of disability in the U.S.1 During this observation, it
is important to consider advances in treatment options, as a multitude
of studies have surfaced that suggest traditional remedies may not be as
safe or effective as once assumed–shedding light on some newer options
that could help relieve joint discomfort for millions.

Given the FDA’s urgent priority on non-pharmacologic approaches to pain
treatment2, treating joint discomfort now has a new
dimension. Findings suggest that some common prescriptions and over the
counter remedies could be ineffective or dangerous:

  • The Lancet published studies
    that show for older patients, acetaminophen provides no more
    osteoarthritis pain relief and improvement in function than a placebo.3
  • According to the American College of Rheumatology, popular
    supplements to treat osteoarthritis, glucosamine and chondroitin,
    show modest to no improvement compared to placebo in pain relief or
    joint damage.4
  • In a recent
    study
    published by The New England Journal of Medicine, the
    FDA called finding non-pharmacologic approaches to pain
    treatment an urgent priority–citing the epidemic of opiate abuse.5
  • According to the Arthritis Foundation, popular nonsteroidal
    anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen
    are options for arthritis pain relief, but serious risks can include
    ulcers, bleeding, heart attack, stroke, and kidney damage. The
    Osteoarthritis Research Society International (OARSI) recommends that
    people at high risk for side effects like cardiovascular disease or GI
    bleeding should avoid using NSAIDs entirely. 6
  • GOPO®
    Rosehip with Galactolipids,
    the UK’s #3 rated joint care
    supplement is the only product of its kind to contain a high level of
    GOPO–a key component of the rose-hip. In a clinical
    study
    conducted at the University of Copenhagen in Denmark, GOPO
    was shown to help reduce joint pain and stiffness in up to 82% of
    people.7*

Jonathan Groves, Jakemans, Inc. president said, “With 1 in 5 adults and
300,000 children affected by arthritis and joint pain, there is a huge
need for additional remedies for these conditions. Doctors and patients
are seeking safer and healthier alternatives to relieve joint pain.
Given the new research and guidelines on over the counter medications
and the dangers of opioid use, those who suffer from joint and arthritis
pain should consider GOPO®
Rosehip with Galactolipids
as a natural alternative for relief–and
it’s backed by numerous research studies.”

Laboratory studies have shown that GOPO can switch off certain genes
responsible for producing proteins and enzymes that have been implicated
in inflammatory joint destruction and switch on genes that help to
produce collagen and cartilage, which are essential components of a
healthy joint.*

GOPO®
Rosehip with Galactolipids
is the only product of its kind to
contain a high level of GOPO–a key component of the rosehip, which may
play a valuable role in the care of joints and joint tissues.*

GOPO® has been evaluated in numerous rigorously-conducted,
placebo-controlled, clinical trials involving hundreds of patients with
difficult-to-treat chronic joint conditions including osteoarthritis and
rheumatoid arthritis. Efficacy results have been consistently positive
and evidence supporting the benefits of GOPO® has been presented around
the world at numerous clinical meetings and many studies have been
published in peer-reviewed journals.*

For more information about GOPO® Rosehip with Galactolipids, please
visit www.gopo.us.

About Jakemans, Inc.

Jakemans, Inc., is the US subsidiary of G.R. Lane Health Products Ltd.
Lanes is one of the major natural medicine companies in the UK. Lanes
manufactures and markets well-known products such as Olbas®, Kalms,
Quiet Life, and Jakemans® Throat & Chest™ Lozenges.

Established in the 1930s by Gilbert Lane – an early supporter of the
idea that we can improve our health through diet and the use of
carefully selected plants and nutrients – Lanes remains a family owned
business and is chaired by Gilbert’s granddaughter, Janet Lane.

__________________

1 Centers for Disease Control and Prevention. Addressing the
nation’s most common form of disability, 2015.

2 New England Journal of Medicine. Feb 4, 2016. A proactive
response to prescription opioid abuse.

3 The Lancet: Bruno R da Costa, PhD, Stephan Reichenbach, MD,
Noah Keller, MMed, Linda Nartey, MD, Simon Wandel, PhD, Prof Peter Jüni,
MD, Dr Sven Trelle, MD, Effectiveness of non-steroidal anti-inflammatory
drugs for the treatment of pain in knee and hip osteoarthritis: a
network meta-analysis. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30002-2/abstract

4 American College of Rheumatology. 2012 Recommendations for
the Use of Nonpharmacological and Pharmacologic Therapies in
Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken).
2012 Apr; 64(4):465-74. Review.

5 The New England Journal of Medicine. Feb 4, 2016. A
proactive response to prescription opioid abuse.

6 The Arthritis Foundation. Feb 22, 2016. 25 Treatments for
Hip and Knee Arthritis Pain.

7 Scandinavian Journal of Rheumatology (August 2005)

*These statements have not been evaluated by the Food & Drug
Administration. This product is not intended to diagnose, treat, cure,
or prevent any disease.

Contacts

Scott Public Relations
Joy Scott, 818-610-0270
joy@scottpublicrelations.com